Search Results - "CROWLEY, John J"

Cure Models as a Useful Statistical Tool for Analyzing Survival by OTHUS, Megan, BARLOGIE, Bart, LEBLANC, Michael L, CROWLEY, John J

“…Cure models are a popular topic within statistical literature but are not as widely known in the clinical literature. Many patients with cancer can be…”
Get full text

The revised TNM staging system for lung cancer by Rami-Porta, Ramon, Crowley, John J, Goldstraw, Peter

“…The International Staging Committee (ISC) of the International Association for the Study of Lung Cancer (IASLC) collected 68,463 patients with nonsmall cell…”
Get full text

Patient Income Level and Cancer Clinical Trial Participation by UNGER, Joseph M, HERSHMAN, Dawn L, ALBAIN, Kathy S, MOINPOUR, Carol M, PETERSEN, Judith A, BURG, Kenda, CROWLEY, John J

“…Studies have shown an association between socioeconomic status (SES) and quality of oncology care, but less is known about the impact of patient SES on…”
Get full text

Prospective analysis of antigen-specific immunity, stem-cell antigens, and immune checkpoints in monoclonal gammopathy by Dhodapkar, Madhav V., Sexton, Rachael, Das, Rituparna, Dhodapkar, Kavita M., Zhang, Lin, Sundaram, Ranjini, Soni, Sonal, Crowley, John J., Orlowski, Robert Z., Barlogie, Bart

“…Blockade of immune checkpoints (ICPs) has led to impressive responses in cancer patients. However, the impact of preexisting immunity and ICPs on the risk of…”
Get full text

The International Association for the Study of Lung Cancer Staging Project: prognostic factors and pathologic TNM stage in surgically managed non-small cell lung cancer by Chansky, Kari, Sculier, Jean-Paul, Crowley, John J, Giroux, Dori, Van Meerbeeck, Jan, Goldstraw, Peter

“…To assess the impact of cell type, age, and gender in addition to pathologic tumor, node, metastasis (TNM) stage in surgically managed stage I-IIIA non-small…”
Get more information

Adult and Pediatric Antibiotic Prophylaxis during Vascular and IR Procedures: A Society of Interventional Radiology Practice Parameter Update Endorsed by the Cardiovascular and Interventional Radiological Society of Europe and the Canadian Association for Interventional Radiology by Chehab, Monzer A., Thakor, Avnesh S., Tulin-Silver, Sheryl, Connolly, Bairbre L., Cahill, Anne Marie, Ward, Thomas J., Padia, Siddharth A., Kohi, Maureen P., Midia, Mehran, Chaudry, Gulraiz, Gemmete, Joseph J., Mitchell, Jason W., Brody, Lynn, Crowley, John J., Heran, Manraj K.S., Weinstein, Jeffrey L., Nikolic, Boris, Dariushnia, Sean R., Tam, Alda L., Venkatesan, Aradhana M.

Get full text

Phase III Trial of Maintenance Gefitinib or Placebo After Concurrent Chemoradiotherapy and Docetaxel Consolidation in Inoperable Stage III Non–Small-Cell Lung Cancer: SWOG S0023 by KELLY, Karen, CHANSKY, Kari, GASPAR, Laurie E, ALBAIN, Kathy S, JETT, James, UNG, Yee C, LAU, Derick H. M, CROWLEY, John J, GANDARA, David R

“…Early clinical studies with gefitinib showed promising efficacy and mild toxicity in patients with advanced non-small-cell lung cancer (NSCLC). Thus, gefitinib…”
Get full text

Phase III Randomized, Intergroup Trial Assessing Imatinib Mesylate At Two Dose Levels in Patients With Unresectable or Metastatic Gastrointestinal Stromal Tumors Expressing the Kit Receptor Tyrosine Kinase: S0033 by BLANKE, Charles D, RANKIN, Cathryn, TANAKA, Michael, HECHT, J. Randolph, HEINRICH, Michael C, FLETCHER, Christopher D. M, CROWLEY, John J, BORDEN, Ernest C, DEMETRI, George D, RYAN, Christopher W, VON MEHREN, Margaret, BENJAMIN, Robert S, RAYMOND, A. Kevin, BRAMWELL, Vivien H. C, BAKER, Laurence H, MAKI, Robert G

“…To assess potential differences in progression-free or overall survival when imatinib mesylate is administered to patients with incurable gastrointestinal…”
Get full text

Surgery With or Without Preoperative Paclitaxel and Carboplatin in Early-Stage Non–Small-Cell Lung Cancer: Southwest Oncology Group Trial S9900, an Intergroup, Randomized, Phase III Trial by PISTERS, Katherine M. W, VALLIERES, Eric, CROWLEY, John J, FRANKLIN, Wilbur A, BUNN, Paul A, GINSBERG, Robert J, PUTNAM, Joe B, CHANSKY, Kari, GANDARA, David

“…PURPOSE Patients with early-stage non-small-cell lung cancer (NSCLC) have a poor prognosis even after complete resection. Earlier studies of preoperative…”
Get full text

Randomized Phase III Clinical Trial Designs for Targeted Agents by Hoering, Antje, Leblanc, Mike, Crowley, John J

“…Purpose: Cancer therapies with mechanisms of action which are very different from the more conventional chemotherapies are now being developed. In this…”
Get full text

Genome-wide association scan for heterotic quantitative trait loci in multi-breed and crossbred beef cattle by Akanno, Everestus C, Chen, Liuhong, Abo-Ismail, Mohammed K, Crowley, John J, Wang, Zhiquan, Li, Changxi, Basarab, John A, MacNeil, Michael D, Plastow, Graham S

“…Heterosis has been suggested to be caused by dominance effects. We performed a joint genome-wide association analysis (GWAS) using data from multi-breed and…”
Get full text

Disease Control Rate at 8 Weeks Predicts Clinical Benefit in Advanced Non–Small-Cell Lung Cancer: Results From Southwest Oncology Group Randomized Trials by LARA, Primo N, REDMAN, Mary W, KELLY, Karen, EDELMAN, Martin J, WILLIAMSON, Stephen K, CROWLEY, John J, GANDARA, David R

“…Tumor shrinkage categorized as complete response (CR) or partial response (PR) is a fundamental efficacy measure for new cancer treatments and often considered…”
Get full text

The Influence of Finasteride on the Development of Prostate Cancer by Thompson, Ian M, Goodman, Phyllis J, Tangen, Catherine M, Lucia, M. Scott, Miller, Gary J, Ford, Leslie G, Lieber, Michael M, Cespedes, R. Duane, Atkins, James N, Lippman, Scott M, Carlin, Susie M, Ryan, Anne, Szczepanek, Connie M, Crowley, John J, Coltman, Charles A

“…This randomized trial tested the idea that finasteride, which inhibits the production of androgens within the prostate, can prevent prostate cancer. The…”
Get full text

Dynamics of Fast and Slow Inhibition from Cerebellar Golgi Cells Allow Flexible Control of Synaptic Integration by Crowley, John J., Fioravante, Diasynou, Regehr, Wade G.

“…Throughout the brain, multiple interneuron types influence distinct aspects of synaptic processing. Interneuron diversity can thereby promote differential…”
Get full text

Underrepresentation of Patients 65 Years of Age or Older in Cancer-Treatment Trials by Hutchins, Laura F, Unger, Joseph M, Crowley, John J, Coltman, Charles A, Albain, Kathy S

“…In the late 1980s and early 1990s, federal agencies established requirements that women and members of minority groups be adequately represented in clinical…”
Get full text

The IASLC Lung Cancer Staging Project: data elements for the prospective project by Giroux, Dorothy J, Rami-Porta, Ramón, Chansky, Kari, Crowley, John J, Groome, Patti A, Postmus, Pieter E, Rusch, Valerie, Sculier, Jean-Paul, Shepherd, Frances A, Sobin, Leslie, Goldstraw, Peter

“…The International Association for the Study of Lung Cancer Retrospective Staging Project culminated in a series of recommendations to the International Union…”
Get more information

Fast Vesicle Replenishment and Rapid Recovery from Desensitization at a Single Synaptic Release Site by Crowley, John J, Carter, Adam G, Regehr, Wade G

“…When the synaptic connection between two neurons consists of a small number of release sites, the ability to maintain transmission at high frequencies is…”
Get full text

Lower Osteopontin Plasma Levels Are Associated With Superior Outcomes in Advanced Non–Small-Cell Lung Cancer Patients Receiving Platinum-Based Chemotherapy: SWOG Study S0003 by MACK, Philip C, REDMAN, Mary W, CHANSKY, Kari, WILLIAMSON, Stephen K, FARNETH, Nichole C, LARA, Primo N, FRANKLIN, Wilbur A, LE, Quynh-Thu, CROWLEY, John J, GANDARA, David R

“…S0003 was a phase III trial of carboplatin/paclitaxel with or without the hypoxic cytotoxin tirapazamine in patients with advanced or metastatic non-small-cell…”
Get full text

Phase II Selection Design Trial of Concurrent Chemotherapy and Cetuximab Versus Chemotherapy Followed by Cetuximab in Advanced-Stage Non–Small-Cell Lung Cancer: Southwest Oncology Group Study S0342 by HERBST, Roy S, KELLY, Karen, REDMAN, Mary, CROWLEY, John J, GANDARA, David R, CHANSKY, Kari, MACK, Philip C, FRANKLIN, Wilbur A, HIRSCH, Fred R, ATKINS, James N, DAKHIL, Shaker R, ALBAIN, Kathy S, KIM, Edward S

“…Randomized clinical trials failed to show a survival benefit for epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors plus concurrent…”
Get full text

Gefitinib Therapy in Advanced Bronchioloalveolar Carcinoma: Southwest Oncology Group Study S0126 by WEST, Howard L, FRANKLIN, Wilbur A, MCCOY, Jason, GUMERLOCK, Paul H, VANCE, Ralph, LAU, Derick H. M, CHANSKY, Kari, CROWLEY, John J, GANDARA, David R

“…Advanced bronchioloalveolar carcinoma (BAC) is a distinct subtype of non-small-cell lung cancer (NSCLC) for which there is currently no optimal therapy. Based…”
Get full text